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Executive Summary 
 
The U.S. Chamber of Commerce, with the Center on Addiction and Drug Abuse at 
Columbia University and the John J. Heldrich Center for Workforce Development, developed 
and produced the  Incidence of Substance Abuse in the Workplace survey to measure employers’ 
perceptions regarding the prevalence of drugs in the workplace, how employee drug use impacts 
their firm, and the effectiveness of company policies in addressing and preventing the incidence 
of substance abuse by employees.  This includes the use of illegal drugs such as marijuana and 
cocaine, legal drugs such as prescription medication, tobacco products, and alcohol. The survey’s 
findings will assist employers by providing new information about company drug policies and 
perceptions nationally, to evaluate their drug and alcohol policies. 
Employers have different perceptions regarding the problem of drugs in the workplace, 
and  have devised a number of strategies to address employee drug use.  The Incidence of 
Substance Abuse in the Workplace  survey finds that: 
•   For many employers, drug use is not perceived as a significant problem.  For 
those that do perceive it as a problem, tobacco and alcohol incur the greatest 
costs. 
 
• Small companies are the most likely to say that drug use by employees is not a 
problem at their firm, and are the least likely, in the past year, to be aware of an 
employee that has come to work under the influence of drugs and alcohol. 
 
• The majority of employers do not believe that drug use has had a big impact on 
health care costs or workers compensation costs.  Employers believe that 
employee drug use contributes to lateness, absenteeism, and overall productivity. 
 
• The survey finds a positive correlation between companies that have a written 
policy and companies that believe their policy is effective. Small companies are 
the least likely to have a written policy and the least likely to say their policy is 
effective.  Large firms are the most likely to have a written policy and the most 
likely to say that policy is effective. 
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• Large and medium sized firms are more likely to have drug testing and drug 
treatment programs than small companies are.  Large companies are the most 
likely to offer a comprehensive package of testing and treatment programs to 
employees with a substance abuse problem.  
 
• Firms offering a comprehensive response and treatment plans are the most likely 
to offer a variety of treatment and prevention options to employees. Small firms 
are the least likely, and large firms are the most likely, to offer a variety of 
treatment and prevention options.  
 
• Firms offering a comprehensive response and testing plan are the most likely to 
have a variety of drug testing programs. Small firms are the least likely, and large 
firms, in general, are the most likely, to conduct drug testing of employees. 
 
Methodology 
 
Sampling 
 
The survey was conducted by the Center for Survey Research and Analysis (CSRA) at 
the University of Connecticut.  The results are based on a total of 2,502 telephone interviews 
completed with personnel managers, designees, or CEO’s at a random sample of for-profit 
businesses with ten or more employees.   
Interviews were conducted from the CSRA's interviewing facility in Storrs, Connecticut, 
using a Computer Assisted Telephone Interviewing (CATI) system.  Professional survey 
interviewers who are trained in standard protocols for administering survey instruments conduct 
all CSRA surveys.  All interviewers assigned to this survey participated in special training 
conducted by senior project staff.   
The draft survey questionnaire and field protocols received extensive testing prior to the 
start of the formal interviewing period, including a total of 100 pre-test interviews which were 
not included in final data.  During the formal interviewing period, interviews were extensively 
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monitored by Center staff to insure CSRA standards for quality were continually met.  Selected 
respondents were recontacted to validate the accuracy of recorded responses. 
The sample was drawn from the ABI Business Database, and consisted of a stratified 
random sample of all businesses in selected SIC codes with ten or more employees in the 
contiguous U.S.  The sample frame excluded known branches of businesses.  Additionally, 
approximately 11% of screened establishments in the sample were also eliminated as branches.  
The sample frame eliminated selected SIC codes (See Table 1) which were believed to contain a 
high percentage of non-profit organizations.  Additionally, all sampled businesses were screened 
and non-profit and governmental organizations (approximately 5% of screened establishments in 
sample) were eliminated.   
The sample was stratified so that small, medium, and large businesses were represented 
in proportion to their percentage of all businesses in the sample frame. (See Table 2) Within each 
stratum, a simple random sample was drawn to insure that the overall data are approximately 
representative of population figures on all key variables.  
Table 1 
Selected SIC Codes Containing Non-Profit Establishments 
SIC Code Definition 
43 U.S. Postal Service 
6011 Federal Reserve Banks 
6019 Central Reserve Depository 
6371 Pension, Health and Welfare Funds 
6732 Trusts, Educational and Religious 
6733 Trusts 
82 Schools and Educational Services 
83 Social Services 
84 Museums, Botanical Gardens, Zoos and Gardens 
86 Membership Organizations 
8733 Noncommercial Research Organizations 
91 – 97 Public Administration 
99 Non-classifiable Establishments 
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Table 2 
Distribution of Firms In Proposed Sample Frame 
(Primary Establishments in Contiguous States Excluding Selected SIC Codes) 
 
Number of Employees Number of Establishments Percent of Total 
10 – 19 659,161 52.4% 
20 – 49 385,838 30.7% 
 50+ 213,790 17.0% 
Total: 1,285,789 100.0% 
   
 
Survey Methodology 
 
Interviews were conducted with the person at each firm who was most knowledgeable 
about substance abuse issues at the firm.  Respondents were selected according to defined 
protocols.  For businesses with an identifiable Director or Manager of Human Resources, this 
individual was initially contacted.  In cases where there was no identifiable Human Resources 
contact, the initial contact was made with a principal business decision maker: typically the 
owner or general manager of the firm.  In all cases, the primary contact was asked to designate 
the appropriate respondent to complete the survey at that firm.  Firms were contacted up to 25 
times to attempt to complete an interview.  Firms which refused to be interviewed were 
contacted at least one additional time by an interviewer trained in “refusal conversion” 
techniques.  
The sample error associated with a survey of this size is +/- 2%, meaning that there is less 
than one chance in twenty that the results of a survey of this size would differ by more than 2% 
in either direction from the results which would be obtained if all for-profit establishments in the 
contiguous U.S. with ten or more employees had been selected.  The sample error is larger for 
sub-groups.  CSRA also attempted to minimize other possible sources of error in this survey. 
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Introduction 
Substance abuse permeates every aspect of society ranging from relationships at home to 
productivity in the workplace. The economic costs of substance abuse are substantial, placing on 
burden on the national health care system, as well as the medical budgets of individual 
households.  In addition, there are the hidden costs of substance abuse, including drug-related 
crime, destruction of families, and loss of friends and other relationships.  When an individual 
abuse drugs, society as a whole pays the price. 
Although certain costs associated with substance abuse are well documented, the 
financial and social impact of substance abuse in the workplace warrants further research, 
particularly since employers across the nation have such a wide variety of approaches to drug 
use.   The gamut of workplace policies addressing the issue of substance abuse varies widely 
among employers from pre-employment screening and random drug testing to the absence of any 
policy or program.     
Drug use, both legal and illegal, is present in the American workplace.  According to a 
1998 survey, nearly 14 million Americans use illegal drugs, and nearly three-quarters of these 
users are employed in American businesses (National Household Survey on Drug Abuse, August 
1998, U.S. Department of Health and Human Services).  The abuse of legal drugs such as 
alcohol and prescription medication adds to the number of employees with a substance abuse 
problem. 
  The use of drugs in the workplace is a problem for employers and employees alike.  
Numerous studies indicate that drug use decreases the efficiency and productivity of employees, 
and increases their risk for accidents and injuries to themselves and their co-workers.  In 1992, 
  7
the National Institute of Drug Abuse and the National Institute of Alcoholism and Alcohol Abuse 
estimated that the use of drugs and alcohol by American workers cost employers over $80 billion 
in lost productivity and employment (National Institute of Drug Abuse and the National Institute 
on Alcoholism and Alcohol Abuse, “The Economic Cost of Alcohol and Drug Abuse,” 1992 
(preprint copy) 5/98, p. 5-1).  Drug users pose risks and incur costs to themselves, their co-
workers, and their employer. 
To increase awareness of these issues among employers, it is important to better 
understand the experience of substance abuse in the workplace, as well as the range of policies 
and programs currently implemented by employers.  This national survey of small, medium, and 
large businesses provides new information to deepen employer understanding of the issue, and to 
increase encourage the business community to take effective actions to address this persistent 
problem in U.S. society, with its many ramifications for workers, families, and children. 
 
The Employer’s Perspective:  How Big A Problem is Employee Drug Use? 
 Incidence of Substance Abuse in the Workplace Survey explores three main topic areas: 
• employers’ perceptions of the prevalence and financial impact of employee substance 
abuse within their firms; 
• compare employers’ perceptions of the prevalence and cost of employee substance 
abuse to the actual prevalence and cost; and 
• employers’ policies and practices that deal with avoiding, detecting and responding to 
employee substance abuse. 
 
 Substance abuse includes the use of illegal drugs such as marijuana or cocaine, legal 
drugs such as prescription medication, tobacco products, and alcohol. 
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Although the majority of respondents said that drug use by employees has a negative 
impact on their firm, the survey indicates that for many employers, substance use by employees 
is not perceived as a serious problem.  A third (33%) of respondents indicate that their firm has 
not incurred costs as a result of substance use by employees.  Less than one third (27%) of 
employers are aware of any employees who have come to work during the past year under the 
influence of alcohol or illicit drugs.   
In addition, half (50%) the employers surveyed report that they do not have any type of 
drug testing program, simply because drug use is not a problem at their firm. Although 54% of 
respondents report that summary termination (firing) is the mandatory response to any evidence 
regarding substance use in violation of company policy, over three fourths (84%) of respondents 
indicate that they have fired one or less employees in the past year because of drug use. 
Although many respondents indicate that drug use by employees is not a problem at their 
firm, the majority of respondents identify one or more substances—both legal and illegal—that 
are subject to abuse and inflict costs on their firm.  Of these substances, alcohol and tobacco are 
identified most frequently as the substances abused by employees.  Almost half (49%) of the 
respondents indicate they incur the greatest cost from alcohol and tobacco.  In contrast, only 8% 
identified illegal drugs as incurring the greatest costs to their company of abused substances.  
Use of prescription drugs accounted for 4% of drug related company costs.   
These figures suggest that employees abuse illegal drugs and prescription drugs far less 
than tobacco and alcohol.  While this is a significant finding, it is also likely that employers find 
it easier to detect and identify alcohol and tobacco use than either illegal drugs or prescription 
drugs. Abuse of prescription drugs, in particular, may be difficult for employers to detect.  
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Employers are faced with the challenge of differentiating between the employee that is taking a 
simple cold remedy, from an employee that is taking a more powerful drug.  Likewise, 
employers must distinguish between those employees who are taking a prescription drug 
responsibly and in the manner in which it is prescribed, from those who are abusing such drugs. 
 
The Impact of Drugs in the Workplace 
The use of drugs can impair the ability of an employee to perform his or her job 
responsibilities in a number of ways,  the survey finds.  Respondents indicate that employee 
substance use incurs costs to their company, including absenteeism, turnover, and overall 
profitability.  Survey respondents indicate that substance use has a significant impact on workers 
being late for work and missing work, with 47% indicating that absenteeism is a significant 
problem, and 44% believing that lateness for work is significantly impacted by employee drug 
use. Approximately one third (30%) of employers report that substance use has a significant 
impact on turnover among their employees. Conversely, fewer employers believe that drug use 
has a negative impact on health care and workers compensation costs.  Slightly more than one 
fourth (28%) of respondents believe that drug use has a significant impact on the cost of health 
care coverage offered to employees.  Even fewer respondents (23%) indicate that employee drug 
use had a significant impact on workers compensation premiums and workplace accidents or 
injuries.  
Finally, overall productivity is believed to suffer, with 42% of employers indicating that 
employee drug use significantly impacts productivity.  Fewer employers express concern about 
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the effect on overall profitability, with slightly more than one third (34%) indicating that drug 
abuse has a significant impact.  
Overall, many employers do not perceive drug use by employees as a problem. Those 
that do cite alcohol and tobacco as the most frequently problematic substances, and many 
employers report that employee drug use has a significant impact on lateness, absenteeism, and 
overall employee productivity. Despite the fact that a majority of respondents indicate that 
employee drug use incurs costs to their company, many employers do not test for drugs, and the 
majority had fired less than two people in the last year because of drug use.   
 
Addressing the Problem  
The way firms perceive employee drug use depends a great deal on the strategies they 
have developed to address the incidence of abuse.  Some firms do not address issues of employee 
drug use problems.  Other firms police drug use extensively.  Still others take a carrot and stick 
approach, instituting drug testing and offering treatment to employees.   
 
Initial Actions 
On discovering the incidence of drug or alcohol use in the workplace, respondents 
indicate that they take a number of initial actions, actions that vary substantially depending on 
whether drugs or alcohol is involved.  Half (50%) of the employers surveyed report that the 
initial action they take when an employee first exhibits signs of alcohol use is that the employee 
receives a warning.  Only 13% of employers say they test that employee for additional drug use.  
Less than 10% of employers refer that employee to voluntary counseling or treatment (6%), 
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require that employee to attend counseling or treatment (3%), suspend the employee (6%), or fire 
the employee (9%).   
An employee is less likely to receive a warning and more likely to be drug tested when 
that employee exhibits signs of drug use.  Nearly one fourth (24%) of respondents report that 
their initial action regarding an employee suspected of drug use is to drug test that employee.  
Another 31% of employers indicate that they initially give the employee a warning. Similar to 
the actions taken when an employee is suspected of alcohol use, few employers refer or require 
the employee to attend counseling or treatment (5% and 4%, respectively), or suspend the 
employee (6%).  However, slightly more employers are willing to fire an employee who exhibits 
signs of drug use (15%) than alcohol abuse (9%).  These figures may indicate that employers 
view drug use as a more serious offense then the use of alcohol. 
 
Company Policies Regarding Drugs in the Workplace 
The companies surveyed can be divided into five categories, based on their drug policies 
and how they address drug use problems in the workplace:  Uninvolved, Summary Termination, 
Treatment Oriented, Testing Oriented, and Comprehensive Response.  The first category consists 
of those companies who have no standard approach for drug use.  One fourth (25%) of survey 
respondents are in this Uninvolved category.  These firms do not test for drugs, either prior to 
hiring or during employee tenure, nor do they offer drug treatment for employees who have a 
substance abuse problem. They do not make it a policy to fire employees immediately for drug 
abuse.  The general policy is a hand-off approach based on the perception that drug use by 
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employees is not a significant problem, and 44% of Uninvolved say that this general policy on 
drug use is effective. 
These companies tend to be fairly evenly distributed across production, trade, and service 
industries (30%, 32%, and 38%, respectively), and almost two-thirds (65%) of Uninvolved 
companies are small companies.  Not surprisingly, these firms are the most likely (81%) to be 
unaware of employees working under the influence of alcohol or illicit drugs in the past year.  
The majority (95%) of uninvolved companies have fired only one or no people over the past year 
because of substance use.  Almost two-thirds (62%) do not have a written policy on substance 
use.  Despite the fact that these firms remain uninvolved with either testing for or treating drug 
abuse, almost half (49%) offer their employees a health insurance policy that covers substance 
abuse treatment.  
The second category (16% of respondents) consists of companies who are also 
uninvolved, neither engaging in drug testing or offering drug treatment.  The difference is that 
for these companies, the standard response to employee drug use is summary termination—to 
fire the employee immediately. Summary Termination companies are fairly evenly distributed 
across production, trade, and service industries (28%, 37%, and 35%, respectively), and 61% are 
small companies.  More than half (57%) of Summary Termination firms have a written policy on 
substance use, and 59% say their general policy on drug use is effective.  Less than half (44%) 
offer employees a health insurance policy that covers substance abuse treatment. 
In keeping with their uninvolved policy, three fourths (75%) of these companies are 
unaware of employees who have come to work under the influence of alcohol or illicit drugs in 
the past year.  And despite the fact that for these firms summary termination is the standard 
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reaction to employee drug abuse, the majority (86%) have fired only one or no employees for 
substance use over the last year.  
The third category of companies are those that offer some type of program for affected 
employees. Among survey respondents, 13% are Treatment Oriented companies.  These 
companies do not test employees for drug use, but offer a variety of assistance and treatment 
programs to help employees control their substance abuse problems.  Companies in the service 
industry are more likely to be treatment oriented than either those in production or trade (43%, 
compared to 30% and 27%, respectively), and slightly more than half (51%) are small 
companies.  
To support their emphasis on treatment and assistance, three fourths (76%) of treatment 
oriented companies offer health insurance that covers substance abuse treatment.  Almost three 
fourths (72%) have a written policy on substance use. Two thirds (66%) of Treatment Oriented 
respondents believe that these policies are effective in addressing employee drug use. 
Three fourths (75%) of Treatment Oriented respondents say that they are unaware of 
employees who have come to work under the influence of alcohol or illicit drugs in the past year, 
somewhat less than either the Uninvolved or Summary Termination firms. Even when drug use 
is identified, it appears to rarely end in termination.  Almost all (94%) of treatment oriented 
companies have fired less than two employees for substance abuse over the last year.  
The fourth category consists of companies that are Testing Oriented, and approximately 
one-fifth (19%) of respondents fall into this segment.  These companies test employees for drug 
use either prior to hiring them, or conduct random drug testing of current employees, and do not 
offer treatment programs or assistance for those employees who are found to have a drug use 
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problem.  Production industries are more likely (43%) to be Testing Oriented than either trade 
industries (33%) or service industries (24%).  Companies located in the South are also more 
likely (43%) to be Testing Oriented than companies located in the Northcentral part of the 
country (26%), the West (20%), or the Northeast (11%).  Half (51%) of the Testing Oriented 
companies surveyed are small companies, with 31% classified as medium and 18% as large.  The 
percentage of small and medium firms is higher for Treatment and Testing Oriented firms than 
either Uninvolved or Summary Termination firms. 
Almost three fourths (72%) of Testing Oriented respondents are unaware of employees 
who have come to work under the influence of alcohol or illicit drugs in the last year, slightly 
less than the previous three categories. Slightly more than three fourths (79%) of Testing 
Oriented respondents have fired less than two employees for substance use over the last year, 
also less than the previous three categories.  Almost one fifth (19%) of these firms fired two to 
five people for substance use over the last year.  This finding suggests that Testing Oriented 
firms are more likely to fire people for drug use than either Uninvolved or Treatment Oriented 
firms, and more than those firms for whom Summary Termination is company policy. 
Slightly more than half (51%) of Testing Oriented companies offer health insurance that 
covers substance abuse treatment.  The majority (83%) of testing oriented companies have a 
written policy on substance use, and three fourths (76%) of them report that their general 
company policy on drug use is effective. 
The survey finds that 28% of companies surveyed offer a comprehensive response to 
drug use by employees.  This last category of companies conduct drug testing and offer treatment 
and assistance programs or referrals to those employees who are found to have a substance use 
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problem.   Almost half (49%) of  these Comprehensive Response companies are production 
industries, with the remainder evenly split between trade and service industries (26% and 25%, 
respectively).  Like Testing Oriented companies, Comprehensive Response companies are most 
likely to be located in the South, with 39% of Comprehensive Response respondents located in 
that region.  Only 11% are located in the Northeast, with the remainder located in the west and 
Northcentral region of the country.  Comprehensive Response firms are the most likely to be 
large companies, with almost half (45%) being large companies.  Of the remainder,  31% are 
medium-sized companies, and 20% are small companies (see Table 1). 
Table 1.  Size of Company vs. Type of Response to Drugs in the Workplace 
Type of Company  Small company (%) Medium company 
(%) 
Large company (%) 
Uninvolved 
 
65 26 9 
Summary Termination 
 
61 31 8 
Treatment Oriented 
 
51 30 19 
Testing Oriented 
 
51 31 18 
Comprehensive 
Response 
38 35 27 
 
Comprehensive Response companies are the most likely (39%) to be aware of employees 
who have come to work under the influence of alcohol or illicit drugs in the past year.  
Comprehensive Response companies are also the most likely to fire people for drug use, with 
less than three fourths (71%) having fired only one or no people for substance use in the last 
year, and nearly one fourth (22%) having fired two to five people in the last year.  
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Nearly three fourths (73%) of Comprehensive Response companies offer health insurance 
that covers substance abuse treatment, more than any other category except Treatment Oriented 
companies.  The majority (95%) of Comprehensive Response companies have a written policy 
on substance use, also more than any other category.   Of all the programs Comprehensive 
Response companies have, 41% believe that pre-employment testing/screening is the most 
effective in addressing employee drug use. Comprehensive Response companies are also the 
most likely to say that company policy is effective, with 84% indicating that their policy is 
effective. 
 
Company Size Matters 
The survey also finds a strong correlation between the size of the firm and employer 
perceptions and policies regarding the incidence of substance abuse in the workplace. In general, 
smaller companies are less likely to say that employee substance abuse incurs costs to their 
company, while large companies are most likely to believe that substance abuse by employees 
incurs costs to their firm.   For instance, 42% of small companies report that drug abuse has a 
significant impact on employees being late for work, as compared to 46% of medium-sized firms 
and 54% of large firms. In another example, 43% of small firms indicate that drugs have a 
significant impact on absenteeism, as compared to 49% of medium and 60% of large firms.  
Overall, small firms are the most likely to say that drugs incur no costs:  40% of small 
companies, 32% of medium-sized companies, and 23% large companies say that employee drug 
abuse does not incur costs for their firm.  Similarly, over three fourths (78%) of small firms are 
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unaware of employees who have come to work in the past year under the influence of drugs or 
alcohol, compared to medium-sized (71%) and large (58%) companies (See Table 2). 
Table 2:  Size of Company and Employer Perceptions 
Size of 
company 
 
Do not believe 
drugs cost their 
firm (%) 
Unaware of 
employees who 
have come to 
work under the 
influence (%) 
Have a written 
drug use policy 
(%) 
Believe policy is 
effective (%) 
Small 
 
40 78 57 63 
Medium 
 
32 70 76 69 
Large 
 
23 58 89 73 
 
End Results:  The Cost and Effectiveness of Company Policy 
Effectiveness 
Having a written policy is a strong indicator of whether a company believes its general 
policy is effective, the survey finds.  Of all respondents with a written policy, 75% of them 
indicate that the general company policy is effective in addressing employee substance use.  Of 
those without a written policy, only 47% believe the general company policy to be effective.   
According to the survey, companies with a comprehensive response to employee drug 
use are the most likely to have a written policy on substance use, and are the most likely to say 
that their company policy is effective (See Table 3). Conversely, uninvolved companies are the 
least likely to have a written policy on substance use, and the least likely to believe their policy is 
effective. This suggests a correlation between firms that have a written substance use policy and 
firms that believe their general policy is effective, with companies that have a written policy on 
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substance abuse more likely to believe their overall policy is effective in addressing employee 
drug use.  
Table 3:   Written Policy on Substance Use vs. Effectiveness of Policy 
Type of company   Have a written policy on 
substance Use (%) 
Believe policy is effective (%) 
Uninvolved 
 
34 44 
Summary Termination 
 
57 59 
Treatment Oriented 
 
72 66 
Testing Oriented 
 
83 76 
Comprehensive Response 
 
95 84 
 
In another comparison, small firms show the least confidence regarding the effectiveness 
of their company drug policy, with 63% indicating their policy is effective. Slightly more than 
two thirds of medium-sized firms indicate their substance abuse policy is effective, while 73% of 
large firms believe their policy is effective. Mirroring this trend, slightly more than half (57%) of 
small companies have a written drug use policy, while 76% of medium-sized and 89% of large 
firms have a written drug use policy (See Table 2). 
Companies with a written policy on substance use are also more likely to fire an 
employee for substance abuse than companies that do not have a written policy.  The majority 
(93%) of companies without a written policy fired less than two people for substance use in the 
last year, as compared to 80% of those with a written policy.  Whereas only 6% of companies 
without a written policy have fired two to five people in the last year, 16% of companies with a 
written policy did so. On a possibly related note, companies without a written policy are less 
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likely to view drug use as a problem among their employees.  When asked where their company 
policy has had the greatest impact, 41% without a written policy said that substance use is a 
problem at their firm, as compared to 61% of those firms with a written policy.  
Employers identified a number of factors that influenced their decision to adopt a written 
policy on substance abuse.  These concerns include about safety, health care costs, worker 
compensation costs, absenteeism, performance problems, government regulation, liability and 
insurance costs, and a sense of social responsibility. No one factor was identified by a majority 
of respondents as the main reason for adopting a written policy.  Employers appear to make the 
decision to adopt a written substance use policy based on a variety of considerations.  
 
Costs 
A third (33%) of employers report that substance abuse does incur bottomline costs to 
their company.  Uninvolved companies are the most likely to say drug use does not impact costs, 
while Comprehensive Response firms are the most likely to say drugs do cost the firm.  Of those 
who believe it does, almost half indicate that alcohol and tobacco cause the greatest cost to their 
company.  This holds across all categories of companies. Substance use incurs the greatest cost 
through absenteeism (47%), lateness (44%), and overall employee productivity (42%).   
Only 23% of overall respondents report that substance use significantly increases 
Workers Compensation premiums or workplace accidents/injuries.  Only 28% of companies 
report that substance abuse increased the cost of their health care coverage offered. In general, 
Comprehensive Response companies are more likely to say that substance use has a significant 
impact on costs, while Uninvolved companies are the least likely to say substance use has a 
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significant impact on cost.  For example, more than a third  (35%) of Comprehensive Response 
companies indicate that substance use significantly hikes Worker’s Compensation premiums 
and/or workplace accidents/injuries, while only 11% of Uninvolved companies felt the same.  
Companies in the Summary Termination, Treatment Oriented, and Testing Oriented categories 
report smaller increases in their costs than Comprehensive Response companies (16%, 20%, and 
30%, respectively).  The same trend holds for the impact on the cost of health care coverage, 
absenteeism, lateness, employee turnover, overall employee productivity, and overall 
profitability.  For each, Comprehensive Response firms express the most concern, and 
Uninvolved express the least, regarding the impact on costs then other categories of companies.  
Likewise, small companies are the least likely to indicate that drug abuse has an impact on costs, 
and large companies are the most likely to say that drug abuse has an impact on costs. 
While for the majority of all employers interviewed, drug use rarely costs the company 
an employee, Comprehensive Response and Testing Oriented companies did fire more people in 
the last year because of substance use.  In the last year, 19% of Testing Oriented and 22% of 
Comprehensive Response firms fired two to five people for substance abuse, compared to 5% of 
Uninvolved and 5% of Treatment Oriented companies.  Only 12% of companies classified as 
Summary Termination fired two to five people for drug abuse.  Despite the fact that for some 
companies summary termination is company policy for addressing employee drug abuse, these 
companies fire fewer people for drug use than companies that test for drugs and companies that 
comprehensively address employee drug use.  
There is little consensus on the effectiveness of the specific programs that employers use 
to reduce costs related to substance abuse.  Slightly less than one fourth (23%) indicate that pre-
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employment drug testing and screening is the most effective program.  An additional 14% favor 
summary termination.  Only 10% see employment drug testing as the most effective means of 
controlling costs. For the remainder, 7% favor direct referral programs (other than EAPs), 4% 
favor drug prevention programs, and 9% favor training supervisors to identify and respond to 
employee drug use. 
 
Prevention and Treatment 
We have noted that companies describe a variety of approaches to employee drug use, 
ranging from a hands-off policy to a comprehensive response.  Of the employers surveyed, only 
20% have established a formal Employee Assistance Program (EAP) that provides confidential 
mental health referral and assessment services sponsored and paid for by the employer.  Only 
Treatment Oriented and Comprehensive Response companies offer EAP programs.  Slightly 
more than half (52%) of Comprehensive Response companies, and slightly less than half (47%) 
of Treatment Oriented companies surveyed have an EAP. Similarly, only Comprehensive 
Response and Treatment Oriented companies provide direct referrals to a treatment program 
other than an EAP, with 57% of both Treatment Oriented and Comprehensive Response 
companies providing such referrals.  
Likewise, the incidence of Treatment Oriented and Comprehensive Response companies 
that provide prevention programs far outweighs that of other company types.  Overall, only 15% 
of employers surveyed provide a prevention program.  None of the Uninvolved, Summary 
Termination, or Testing Oriented companies surveyed provide employees with a substance abuse 
prevention program, whereas 27% of Treatment Oriented and 43% of Comprehensive Response 
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companies do provide such programs.  Comprehensive Response and Treatment Oriented 
companies are also the most likely to sponsor a program to assist employees in their efforts to 
quit smoking (23% and 14%, respectively).  Less than 10% of Uninvolved, Summary 
Termination, and Testing Oriented companies do the same (4%, 6%, and 7%, respectively).   
In response to the problem of tobacco use in the workplace, more than half (52%) of the 
firms surveyed maintain a smoke-free workplace.  An additional 37% provide a designated 
smoking area in their facility.  Only 11% of firms do not restrict smoking in any way.  Tobacco 
use is probably the easiest substance for employers to address, by eliminating or restricting 
smoking in the workplace.  Such measures are generally supported by federal and state laws that 
restrict smoking in public buildings and other workplace areas.  
More than half (59%) of employers have a health coverage policy that covers substance 
abuse treatment.  Treatment Oriented and Comprehensive Response companies are the most 
likely to offer employees health insurance that includes coverage for drug abuse treatment. As 
can be seen in Table 4, 76% of Treatment Oriented companies and 73% of Comprehensive 
Response companies offer this coverage.  Summary Termination firms are the least likely to 
offer coverage. 
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Table 4.  Companies that Offer Coverage for Drug Abuse Treatment 
Type of company  Offer health insurance 
(%) 
Offer coverage for drug 
abuse treatment (%) 
Uninvolved 88 49 
 
Summary Termination 87 44 
 
Treatment Oriented 96 76 
 
Testing Oriented 91 51 
 
Comprehensive Response 97 73 
 
 
A number of employers train supervisors to identify and respond to substance abuse, with 
42% of companies indicating they provide this service.  Nearly half (47%) of Testing Oriented 
companies and nearly three fourths (72%) of Comprehensive Response companies train 
supervisors to identify and respond to substance abuse. For other types of companies, 32% of 
Summary Termination and 40% of Treatment Oriented companies train supervisors in substance 
abuse response.   In keeping with their neutral status, only 13% of Uninvolved companies train 
supervisors in substance abuse issues.   
Overall, 32% of respondents indicate that they mandate pre-employment drug testing.  
The majority (60%) of Testing Oriented and Comprehensive Response (74%) companies 
perform this testing.  For current employees, 36% of employers perform drug testing based on 
suspicion.  Testing Oriented and Comprehensive Response companies are the only firms that 
indicate they engage in this activity, with 73% of Testing Oriented and 83% of Comprehensive 
Response indicating that they perform drug tests based on suspicion alone.  These firms are also 
the only ones to perform random drug testing of employees.  Almost half  (49%) of Testing 
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Oriented and more than half (59%) of Comprehensive Response companies perform random 
drug testing of employees.  
In looking at company size, small companies are least likely to drug test an employee 
who exhibits signs of using alcohol and drugs. Small companies are also the least likely to offer 
health insurance benefits that include coverage for substance abuse, have an EAP, refer 
employees to other assistance programs, maintain a prevention program or sponsor a program to 
assist employee efforts to quit smoking, mandate summary termination, or train supervisors to 
identify and respond to substance abuse.  In almost all instances, large companies are the most 
likely to offer such incentives and assistance.  In terms of disincentives, small companies are the 
least likely to conduct mandatory drug testing, drug testing based on suspicion, or random drug 
testing. Large companies are generally the most likely to conduct these types of drug testing.  
For those employees who test positive for drugs, 26% of companies fire the employee 
immediately.  Another 13% of firms issue a warning.  At 12% of firms, the employee is required 
to attend counseling or treatment, and 4% are referred to voluntary counseling or treatment.  At 
36% of firms, a combination of these strategies is employed.   
Employers indicate that there are a variety of reasons why their companies do not have 
any drug testing programs, including the size of the company, expense of conducting drug 
testing, lack of human resources, and fear of litigation.  Half of those surveyed do not have any 
drug testing programs because drug use is not a problem among their employees.  Slightly less 
than one fourth (24%) indicate that the reason they do not have any drug testing programs is 
because their firm is too small.  Less than 5% of employers indicate that high expense (4%), lack 
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of human resources (1%), and fear of litigation (1%) as reasons for not conducting mandatory 
drug testing.   
How effective are these prevention and treatment efforts? Overall, there is little 
consensus on what area company policies have the greatest impact.  Nearly half (46%) of those 
surveyed indicate their policy has no impact because drug use by employees as drug use is not a 
problem. Almost equal numbers of small, medium, and large companies say they do not have a 
drug testing program because drugs are not a problem at their firm (53%, 55%, and 53%, 
respectively).   
An additional 10% of all respondents indicate that their policy has been most effective in 
improving employee performance.  Less than 10% of employers indicate that their policy 
significantly impacts accidents and workers compensation (7%), reducing absenteeism (8%), 
reducing turnover (6%), and reducing health care costs (2%). 
 
Findings 
The survey and our analysis reveals that employees will find a wide divergence of 
perceptions of and approaches to workplace drug abuse across the country.  The Incidence of 
Substance Abuse in the Workplace  survey finds that: 
•   For many employers, drug use is not perceived as a significant problem.  For 
those that do perceive it as a problem, tobacco and alcohol incur the most 
significant costs. 
 
• Small companies are the most likely to say that drug use by employees is not a 
problem at their firm, and are the least likely, in the past year, to be aware of an 
employee that has come to work under the influence of drugs and alcohol 
 
• The majority of employers do not believe that drug use has a big impact on health 
care costs or workers compensation costs.  Many employers believe that 
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employee drug use has a significant impact on lateness, absenteeism, and overall 
productivity. 
 
• There is a positive correlation between companies that have a written policy and 
companies that believe their policy is effective. Small companies are the least 
likely to have a written policy and the least likely to say their policy is effective.  
Large firms are the most likely to have a written policy and the most likely to say 
that policy is effective. 
 
• Large and medium sized firms are more likely to have drug testing and drug 
treatment programs than small companies are.  Large companies are the most 
likely to offer a comprehensive package of testing and treatment programs to 
employees with a substance abuse problem.  
 
• Comprehensive Response and Treatment firms most likely to offer a variety of 
treatment and prevention options to employees. Small firms are the least likely, 
and large firms are the most likely, to offer a variety of treatment and prevention 
options.  
 
• Comprehensive Response and Testing firms most likely to have a variety of drug 
testing programs. Small firms are the least likely, and large firms, in general, are 
the most likely, to conduct drug testing of employees. 
 
 
Conclusion 
 
Substance abuse impacts every aspect of society, from personal relationships to 
productivity in the workplace. The social and economic costs of substance abuse are substantial, 
placing on burden on the national health care system, and contributing to drug-related crime, 
destruction of families, and loss of friends and other relationships.  Substance abuse by one 
person affects many. 
While some employers do not perceive drug use by employees as a significant problem, 
the majority of employers continue to struggle with the incidence of substance abuse in the 
workplace and its associated costs.  Alcohol and tobacco frequently cited as problem substances 
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in the workplace, although illegal drugs such as marijuana and prescription medication are also 
subject to abuse by employees. In response, firms of all sizes are employing a range of strategies 
to prevent and address drug use in the workplace, with varying degrees of success.  As 
employers continue to face the problem of employee substance abuse, the strategies they employ 
to address it must be refined and improved. 
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APPENDIX A 
SURVEY QUESTIONNAIRE 
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APPENDIX B 
SURVEY MARGINALS 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
